Prot# EPO-AKD-3001: A Rndmzd, Open-Lbl, Mltcntr Stdy of Epoetin Alfa Comparing 2 Extended-Dosing Regimens, 1x-Weekly & Every-2-Weeks, w/the 3x-Weekly Dosing Regimen for Initiation & Maintenance Treatment in Anemic Sbjts w/Chronic Kidney Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date12/13/06 → 9/17/08

Funding

  • Quintiles, Inc. (EPO-AKD-3001)
  • Janssen Research & Development, LLC (EPO-AKD-3001)